ASHLEY KENTOSKI: Open Payments
NPI 1457580193 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$812 in 39 payments from 18 companies in 2025. Trend: 2023 $187 · 2024 $802 · 2025 $812
Food & beverage: $812
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $170 |
| ABBVIE INC. | 5 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $62 |
| Exact Sciences Corporation | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $44 |
| Lundbeck LLC | 2 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Dexcom, Inc. | 1 | $31 |
Products named: Ozempic, REXULTI, Wegovy, CAPLYTA, Cologuard Collection Kit, AIRSUPRA, UBRELVY, LEQVIO.
Industry payments across PA — which companies pay providers there.
